期刊
CELL DEATH & DISEASE
卷 13, 期 9, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41419-022-05164-2
关键词
-
类别
资金
- National Natural Science Foundation of China [81972773]
- Overseas Expertise Introduction Project for Discipline Innovation (111 Project) [111-2-12]
- Scientific Research Project of Hunan Provincial Health Commission [20200216, 2021JJ70056]
- Shenzhen Science and Technology Innovation Commission [JCYJ20190809103203711]
- Changsha Municipal Natural Science Foundation [kq2014211]
This study reveals that TGF-beta-induced LINC00152 promotes metastasis in lung adenocarcinoma through the involvement of HuR and the regulation of transcription factors ZEB1, SNAI1, and SNAI2, which ultimately leads to epithelial-mesenchymal transition and enhanced metastatic ability.
Lung adenocarcinoma (LUAD) is one of the main causes of cancer-related mortality, with a strong tendency to metastasize early. Transforming growth factor-beta (TGF-beta) signaling is a powerful regulator to promote metastasis of LUAD. Here, we screened long non-coding RNAs (lncRNAs) responsive to TGF-beta and highly expressed in LUAD cells, and finally obtained our master molecular LINC00152. We proved that the TGF-beta promoted transcription of LINC00152 through the classical TGF-beta/SMAD3 signaling pathway and maintained its stability through the RNA-binding protein HuR. Moreover, LINC00152 increased ZEB1, SNAI1 and SNAI2 expression via increasing the interactions of HuR and these transcription factors, ultimately promoting epithelial-mesenchymal transition of LUAD cell and enhancing LUAD metastasis in vivo. These data provided evidence that LINC00152 induced by TGF-beta promotes metastasis depending HuR in lung adenocarcinoma. Designing targeting LINC00152 and HuR inhibitors may therefore be an effective therapeutic strategy for LUAD treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据